Cantai Therapeutics

Healthcare & Life Sciences

Recent Finacing

Recent Raise

Cantai Therapeutics develops cytokine-targeting bispecific antibodies for autoimmune and inflammatory disorders.

Total Funding

Headquarters

Founded

Website

Focus Areas

Biopharmaceutical

Cytokine-Targeting Bispecific Antibodies

Autoimmune Disorders

Inflammatory Disorders

Drug Development

Therapeutic Services

Investors